EUVIMEDEUVIMED entdecken
Crossref

Disproportionality analysis of flutamide- or bicalutamide-induced liver injury with and without steroids by using the Japanese Adverse Drug Event Report database

Tomoyuki Yamada, Saori Tanaka, Takumi Noda, Kazuya Urashima, Ayumi Fujimoto, Yuka Kohda, Ryuji Kato

International Journal of Clinical Pharmacy · 2025

DOI: 10.1007/s11096-024-01814-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Tomoyuki Yamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Daigaku-machi 2-7, Takatsuki, Osaka, 569-8686, Japan. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Androgen Antagonists, Anilides, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although the mechanism underlying flutamide- or bicalutamide-induced liver injury may be immune related, the details remain unclear. If this mechanism is immune related, steroid use may be considered as a treatment option. AIM: Disproportionality analysis was conducted to evaluate the effect of concomitant steroid use on flutamide- and bicalutamide-induced liver injury. METHOD: Male patients aged 20 years or older who were receiving nonsteroidal anti-androgens from April 2004 to October 2023 were screened from the Japanese Adverse Drug Event Report database. Data on liver injury, age, weight, height, steroid use, obesity, hepatic stenosis, alcohol-related hepatic disorders, hepatitis B and C, and common drugs known to cause drug-induced liver injury were analyzed. Liver injury was defined by the Standardized Medical Dictionary for Regulatory Activities query index (code 20000006, version 27.0). RESULTS: Among 142,430 patients, 2,316 were administered nonsteroidal anti-androgens. Reports of liver injury were disproportionate depending on the agents used (reporting odds ratio [ROR], 1.29; 95% confidence intervals [CI], 1.13-1.46), especially among flutamide or bicalutamide users (flutamide: ROR, 6.09; 95% CI, 4.51-8.23; bicalutamide: ROR, 1.24; 95% CI, 1.05-1.48). Multivariable logistic regression analysis correlated steroid use with a lower risk of flutamide- or bicalutamide-induced liver injury (flutamide: odds ratio, 0.07; 95% CI, 0.01-0.52; bicalutamide: odds ratio, 0.45; 95% CI, 0.21-0.96). CONCLUSION: Our findings suggest that flutamide and bicalutamide may increase the risk of liver injury compared to enzalutamide, apalutamide, and darolutamide. Furthermore, our study indicated that steroid use could aid in the management of liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsAndrogen AntagonistsAnilidesChemical and Drug Induced Liver InjuryFlutamideNitrilesSteroidsTosyl CompoundsAdultAgedAged, 80 and overHumansMaleMiddle AgedYoung AdultDatabases, FactualJapanNonsteroidal Anti-AndrogensRetrospective Studies

Stichwörter der Autor:innen

Adverse drug eventBicalutamideChemical and drug induced liver injuryFlutamideJapanese Adverse Drug Event Report databasePharmacovigilanceSteroids

Substanzen

Androgen AntagonistsAnilidesbicalutamideFlutamideNitrilesNonsteroidal Anti-AndrogensSteroidsTosyl Compounds

Autor:innen und Institutionen

  • Department of Pharmacy, Osaka Medical and Pharmaceutical University Hospital, Daigaku-machi 2-7, Takatsuki, Osaka, 569-8686, Japan.
  • Department of Pharmacotherapeutics and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Nasahara 4-20-1, Takatsuki, Osaka, 569-1094, Japan.
  • Department of Pharmacotherapeutics and Toxicology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Nasahara 4-20-1, Takatsuki, Osaka, 569-1094, Japan. ryuji.kato@ompu.ac.jp.

Zitieren

APA

Yamada, T., Tanaka, S., Noda, T., Urashima, K., Fujimoto, A., Kohda, Y., & Kato, R. (2025). Disproportionality analysis of flutamide- or bicalutamide-induced liver injury with and without steroids by using the Japanese Adverse Drug Event Report database. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01814-x

Vancouver

Yamada T, Tanaka S, Noda T, Urashima K, Fujimoto A, Kohda Y, et al. Disproportionality analysis of flutamide- or bicalutamide-induced liver injury with and without steroids by using the Japanese Adverse Drug Event Report database. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-024-01814-x

BibTeX
@article{Yamada2025,
  author = {Yamada, Tomoyuki and Tanaka, Saori and Noda, Takumi and Urashima, Kazuya and Fujimoto, Ayumi and Kohda, Yuka and Kato, Ryuji},
  title = {Disproportionality analysis of flutamide- or bicalutamide-induced liver injury with and without steroids by using the Japanese Adverse Drug Event Report database},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  doi = {10.1007/s11096-024-01814-x}
}
Kostenlos starten →